DuPont Decomposition

Why does THYROCARE earn its ROE?

Breaking down Return on Equity into profitability, efficiency, and leverage.

ROE = Net Margin × Asset Turnover × Equity Multiplier

27.9% = 19.8% × 1.10 × 1.28

Latest: FY2026

Profitability

Net Margin

19.8%

29.9% →19.8%

How much profit per ₹ of revenue

Efficiency

Asset Turnover

1.10x

0.97x →1.10x

Revenue per ₹ of assets

Leverage

Equity Multiplier

1.28x

1.15x →1.28x

Assets funded by equity vs debt

Trend Analysis

ROE declined by 5.6 pp over 5 years. Driven by net margin declining (29.9% → 19.8%), asset turnover improving (0.97x → 1.10x).

Historical Decomposition

Last 5 years

YearRevenuePATNet MarginAsset TOLeverageROE
FY20220Cr0Cr29.9%0.971.1533.5%
FY20230Cr0Cr12.5%0.821.1812.1%
FY20240Cr0Cr12.5%0.881.2213.4%
FY20250Cr0Cr13.4%0.981.2716.7%
FY20260Cr0Cr19.8%1.101.2827.9%

How to read DuPont

  • Rising ROE from margin = pricing power, operational improvement (good)
  • Rising ROE from turnover = better asset utilization (good)
  • Rising ROE from leverage = more debt, amplified risk (caution)
  • Falling ROE across all three = structural deterioration (red flag)

See DCF fair value for THYROCARE

Combine financial quality with intrinsic value.

See Fair Value →

DuPont decomposition from audited annual financials. Factual analysis, not investment advice.

THYROCARE DuPont Analysis — ROE 27.9% | YieldIQ